No antibiotic candidates for killing superbugs

Japan’s pharmaceutical industry doesn’t have even a single candidate for new antibiotics to counter multidrug-resistant superbugs such as some types of Acinetobacter and E. coli bacteria, according to an expert reporting the situation to the government.

Shuhei Fujimoto, a professor at Tokai University’s Department of Bacteriology and Bacterial Infection, said he alerted the Health, Labor and Welfare Ministry’s study group on superbugs to the lack of new antibiotics indispensable to treat people infected with such bacteria.

"Although the battle with multidrug-resistant bacteria has long been buttressed by developments of new antibiotics, we are in a critical situation at present," he said.

Low profitability of antibiotics appears to be a factor behind pharmaceutical manufacturers’ reluctance to make developmental efforts for new antibiotics, he said.

Read the rest of the story: No antibiotic candidates emerge to stem superbugs.

Japan detects superbug NDM-1

Japan on Monday said it has detected its first case of an antibiotic-resistant "superbug" that surfaced in South Asia and has triggered a global health alert.

A hospital linked to the Dokkyo Medical University in Tochigi prefecture north of Tokyo detected a drug-resistant "superbug", a bacterium carrying the New Delhi metallo-lactamase-1 (NDM-1) gene, in a patient last year, a hospital official told AFP.

The case follows a warning from the World Health Organization (WHO) last month calling on global health authorities to monitor the drug-resistant superbug that is believed to have spread from India.

"A patient who came home from India, in his 50s, had fever symptoms while he was hospitalised in May last year, and after a blood test the hospital detected an antibiotics-resistant bacterium," the official said, adding that the patient fully recovered.

via Japan detects its first case of NDM-1 superbug.